FindTrial
Sign In

To find out predictors of failure of High Flow Nasal Cannula Oxygen therapy in children.

PREDICTORS OF FAILURE OF HIGH FLOW NASAL CANNULA OXYGEN THERAPY IN CHILDREN

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/03/032301
Enrollment
60
Registered
2021-03-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J962- Acute and chronic respiratory failure

Interventions

None listed

Sponsors

Maulana Azad Medical College and associated Lok Nayak Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All children 1 month to 12 years of age started on HFNC therapy.

Exclusion criteria

Exclusion criteria: Children having underlying Cyanotic heart diseases

Design outcomes

Primary

MeasureTime frame
Impact of initial SpO2/FiO2 ratio on failure of HFNC therapy in children.Timepoint: O hours (initial, at time of admission in PICU)—

Secondary

MeasureTime frame
1. Impact of degree of improvement seen at 2 hours and 6 hours in SpO2/FiO2 ratio and Respiratory Clinical Score (RCS) on failure of HFNC therapy in children. 2. Effect of other factors like age, underlying disease etiology and disease severity (by PRISM III score) on failure of HFNC therapy. Timepoint: 2 hours and 6 hours—

Countries

India

Contacts

Public ContactDr Urmila Jhamb

Maulana Azad Medical College and associated Lok Nayak Hospital

ujhamb@hotmail.com9968604309

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026